- State Covid panel warns against school crowding
Images of smiling children playing together in schools and chatting up classmates over midday meals are an encouraging pointer to return to normalcy but crowding and queueing up should not be allowed, say public health experts. The state’s technical advisory committee on Covid-19 is set to take up the matter on Thursday.
- Karnataka reports 5 more suspected cases
A day after two suspected cases of AY.4.2 variant of the coronavirus was detected in Karnataka , five more suspected cases of the new variant have been detected taking the total to seven, said state health and family welfare commissioner D Randeep on Wednesday.
- Since new SOP, 313 from ‘at risk’ nations landed at KIA
Barely 48 hours after the state government issued new guidelines for international passengers from nine high risk countries where Covid cases are surging, 313 travellers from these nations arrived in Bengaluru.
- India has 17.7% of world population, gave 15% of global jabs; China, EU, US all fare better
That India has managed to administer more than one billion doses of vaccines is no small feat, and is indicative of the fact that despite its huge population, it has managed to procure and provide vaccines for a large number of people.
- Merck to share formula for Covid pill with poor countries
Merck has granted a royalty-free license for its promising Covid-19 pill to a UN-backed nonprofit in a deal that would allow the drug to be manufactured and sold cheaply in the poorest nations, where vaccines for the coronavirus are in devastatingly short supply. The agreement with the Medicines Patent Pool, an organisation that works to make medical treatment and technologies globally accessible, will allow companies in 105 countries.
- Schools ask parents for vaccination certificates
An increasing number of private schools that are preparing to resume physical classes for lower primary school students after Deepavali are asking parents to furnish vaccination certificates. Other school managements have requested undertakings from parents stating that they are vaccinated.
- India seeks vaccine loans from ADB, AIIB
The Government of India has applied for loans from the Asian Development Bank (ADB) and the Asian Infrastructure Investment Bank (AIIB) to procure as many as 667 million doses of COVID-19 vaccines.
- AY4.2 Variant ‘infrequent’ in India: INSACOG
The latest mutation of the coronavirus variant, AY4.2, which has been linked to a rise in cases in the United Kingdom, is “very infrequent” in India, according to a weekly report by the India SARS-CoV-2 Genome Consortium (INSACOG), the body that tracks the emergence of new variants, on Wednesday.
- ‘Knock every door’ campaign to boost second-dose vaccination
Health Minister Mansukh Mandaviya said on Wednesday that there were more than 10.34 crore people in the country who had missed the second dose of COVID-19 that they were due to take.
- US clears Covaxin trial participants for travel
At a time when WHO is dithering on granting emergency use listing to Covaxin, the US CDC has paved the way—with a rider—for people vaccinated with the Bharat Biotech jab to travel to the US. It has put Covaxin on the list of qualifying vaccine candidates for exception under the category of “participants in certain Covid-19 vaccine trials”, but it is unclear if all Covaxin jabbed can avail the exemption or if it is only for those who took part in phase-3 trials.